Position in VRTX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$3,364,678
+$191,613 QoQ
Shares Held
7,535
+7.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 96.2972793629728.ToString("F0")%
Shared 0.ToString("F0")%
None 3.7027206370272063.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026COMMERCE BANK holds $27,782,414 across 24 Biotechnology names. VRTX ranks #3 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,448 | $4,981,982 | |
| 2 | EXEL |
Exelixis, Inc.
|
88,824 | $3,809,659 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
7,535 | $3,364,678 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,480 | $3,136,646 | |
| 5 | MRNA |
Moderna, Inc.
|
48,508 | $2,464,206 | |
| 6 | INCY |
Incyte Corp
|
19,518 | $1,837,033 | |
| 7 | TECH |
BIO-TECHNE Corp
|
34,131 | $1,783,685 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
17,860 | $1,154,291 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,364,678 | 7,535 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,173,065 | 6,999 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,714,848 | 6,932 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $3,334,548 | 7,490 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $4,044,852 | 8,343 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $3,478,522 | 8,638 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,461,589 | 7,443 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $3,125,424 | 6,668 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,783,946 | 6,660 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $2,857,994 | 7,024 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,411,576 | 6,935 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,481,317 | 7,051 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,130,502 | 6,762 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $2,082,969 | 7,213 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,951,788 | 6,741 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,879,256 | 6,669 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,765,983 | 6,767 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,183,423 | 5,389 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $893,345 | 4,925 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,052,306 | 5,219 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,190,060 | 5,538 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $1,223,058 | 5,175 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,493,666 | 5,489 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $1,434,711 | 4,942 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $1,371,305 | 5,763 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||